Icu Medical Inc/de Form 4 insider transactions
NASDAQ
Form 4: ICU Medical CEO Vivek Jain Reports Stock Transactions Following Vesting of Restricted Stock Units
ICU Medical's CEO, Vivek Jain, reports the acquisition and disposal of common stock following the vesting of restricted stock units and performance-based restricted stock units.
NASDAQ
Virginia Sanzone, VP and General Counsel of ICU Medical, reports the acquisition and disposal of common stock and derivative securities, including restricted stock units and performance-based restricted stock units.
NASDAQ
Director George A. Lopez of ICU Medical Inc. reports the sale of common stock shares over three days in March 2024.
NASDAQ
Christian Voigtlander, Chief Operating Officer of ICU Medical, Inc., sold shares of common stock in a series of transactions on March 4, 2024.
NASDAQ
Smiths Group PLC, a former 10% owner of ICU Medical Inc., sold 830,000 shares of common stock at a price of $106.075 per share on February 29, 2024, reducing its holdings to 1,670,000 shares.
NASDAQ
Smiths Group International Holdings Ltd, a former 10% owner of ICU Medical Inc., disposed of 830,000 shares of common stock at a price of $106.075 per share on February 29, 2024, reducing its holdings to 1,670,000 shares.